Medicines and Healthcare products Regulatory Agency (MHRA) has approved the use of UK‑donor plasma for five high‑priority plasma-derived medicinal products.

Blood in test tubes.
Following an extensive safety review, the Medicines and Healthcare products Regulatory Agency (MHRA) has approved the use of UK‑donor plasma for five high‑priority medicines, helping to strengthen supplies of life-saving treatments used by thousands of critically ill patients each year.
The decision, announced today (9 July 2026), follows an assessment of the potential risk of









